Skip to main content
usedby
CausalyusedbyManas AI

How Manas AI uses Causaly

ConfirmedVendor case study · Checked Oct 8, 2026
View captured proof

The use case: how Manas AI deploys Causaly

Manas AI uses Causaly as its primary platform for target identification and validation in drug discovery, running evidence assessments across human genetics, preclinical, clinical, competitor and safety data before committing resources to a target. It also uses the platform as a sanity check at later pipeline stages.

In the customer’s words

Companies live and die based on the identification and veracity of their targets. If you make a mistake at the very first step, every step that follows will be a snowball effect from that initial wrong decision.
Dr. Siddhartha Mukherjee, Co-founder, Manas AI — Source

Causaly users in Biotech & Pharma

Companies in the same sector, with public evidence.

EisaiConfirmedProQRConfirmedAgomabObservedBioAgeObservedIpsenObservedLundbeckObserved
See all Causaly customers

More stories

Go straight to the source

Based on Causaly’s published case study. We check the public evidence; the results are reported by the vendor.

causaly.com
Source published
Jun 29, 2026
Last checked
Oct 8, 2026
causaly.comCaptured Causaly case study about Manas AIOpen source capture
What the story claims, and what we checked

What we compared with the page.

  • The passage quoted aboveChecked

    Copied word for word from the page, near the name of Manas AI.

  • The publication dateChecked

    Read from the page’s own metadata, never guessed.

  • Manas AI uses CausalyChecked

    Confirmed line.

  • The result itselfNot checked

    We quote it; we did not measure it.

Manas AI uses Causaly as its primary platform for target identification and validation. When a candidate target is identified, whether starting from a disease pathway or from a protein family with known druggability, the team uses Causaly to run a comprehensive evidence assessment before committing resources.
From the page. causaly.com